Implant Sciences
(OTCQB:IMSC) reported Thursday it has hired software quality assurance
engineer Charles Fertitta as quality manager in a move to maintain
quality standards amid production volume growth.
The company,
which supplies detection systems for homeland security and defence
markets saw its share price rise 7.5 cents, or 10.36 percent, climbing
to 80 cents each on the OTC market.
Fertitta, who is a certified
software tester, was a senior software quality assurance engineer at
Reveal Imaging Technology and PHT Corp., and holds a bachelor of science
in business management from Franklin Pierce College.
Prior to
these positions, he held a number of engineering, manufacturing and
quality assurance jobs at L3 Communications Security and Detection
Systems.
In a statement, chief executive Glenn D. Bolduc said:
“With the hiring of Charles Fertitta as Quality Manager, Andy Anderson
as Director of Engineering, and Bill McGann as COO (chief operating
officer), Implant Sciences has added significant security industry experience to our management team.
“These three individuals greatly expand our ability to meet the needs of our growing customer base.”
Last month, the company named Bill McGann as chief operating officer and as a member of the board of directors.
As
a pioneer in the explosive trace detection industry, McGann co-founded
Ion Track instruments, the first explosive trace detection provider to
get certification from the US Transportation Security Administration.
With
over 70 research proposals to his name, McGann has authored 20
scientific publications and over 25 patents in the nuclear, chemical and
biological detection technologies.
In recent months the company
has signed contracts to supply its detection equipment to clients in
Africa, the Middle East, China and Japan.
Implant Sciences'
systems are used by private companies and government agencies to screen
baggage, cargo, vehicles, among other objects, and people for the
detection of trace amounts of explosives.
The QS-H150 is a
handheld explosives trace detector that rapidly detects trace amounts of
a number of military, commercial, and homemade explosives. The QS-H150
uses no radioactive materials.
Implant's other main product, the
Quantum Sniffer QS-B220, which was introduced in May 2011, is a trace
detector that uses ion mobility spectrometry to identify a number of
military, commercial and homemade explosives and narcotic substances.
The
benchtop explosives and narcotics detector is suited for a number of
security settings, including high-traffic airports, borders, and
prisons.
In December, the QS-B220 device received CE
Certification, an important step for generating sales in Europe, and in
February, achieved ASTM E2520-07 certification.
No comments:
Post a Comment